Ceapro Inc
XTSX:CZO
Balance Sheet
Balance Sheet Decomposition
Ceapro Inc
Ceapro Inc
Balance Sheet
Ceapro Inc
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
2
|
9
|
6
|
2
|
2
|
5
|
8
|
14
|
9
|
|
| Cash Equivalents |
0
|
2
|
9
|
6
|
2
|
2
|
5
|
8
|
14
|
9
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
3
|
4
|
2
|
2
|
3
|
0
|
|
| Accounts Receivables |
0
|
1
|
1
|
1
|
3
|
4
|
2
|
2
|
3
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
4
|
11
|
9
|
6
|
6
|
9
|
12
|
21
|
15
|
|
| PP&E Net |
6
|
10
|
14
|
17
|
18
|
20
|
19
|
17
|
16
|
15
|
|
| PP&E Gross |
6
|
0
|
0
|
17
|
18
|
20
|
19
|
17
|
16
|
15
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
4
|
4
|
6
|
8
|
10
|
12
|
13
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
8
N/A
|
16
+104%
|
26
+68%
|
28
+5%
|
25
-9%
|
27
+8%
|
29
+7%
|
31
+6%
|
38
+22%
|
31
-17%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
5
|
3
|
4
|
1
|
2
|
1
|
1
|
2
|
2
|
|
| Long-Term Debt |
3
|
3
|
1
|
1
|
0
|
3
|
3
|
2
|
2
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
8
+40%
|
4
-49%
|
5
+32%
|
2
-60%
|
5
+135%
|
5
-1%
|
3
-32%
|
5
+63%
|
4
-34%
|
|
| Equity | |||||||||||
| Common Stock |
7
|
7
|
15
|
16
|
16
|
16
|
17
|
17
|
17
|
17
|
|
| Retained Earnings |
5
|
0
|
4
|
3
|
2
|
1
|
3
|
6
|
11
|
6
|
|
| Additional Paid In Capital |
1
|
1
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
8
+277%
|
22
+184%
|
23
+1%
|
23
+3%
|
22
-4%
|
24
+9%
|
28
+14%
|
32
+16%
|
28
-14%
|
|
| Total Liabilities & Equity |
8
N/A
|
16
+104%
|
26
+68%
|
28
+5%
|
25
-9%
|
27
+8%
|
29
+7%
|
31
+6%
|
38
+22%
|
31
-17%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
61
|
62
|
75
|
76
|
77
|
77
|
78
|
78
|
78
|
78
|
|